Acebutolol: Difference between revisions

Jump to navigation Jump to search
mNo edit summary
 
mNo edit summary
Line 17: Line 17:
==FDA Package Insert==
==FDA Package Insert==


 
====SECTRAL (acebutolol hydrochloride) capsule====


'''  [[Acebutolol indications and usage|Indications and Usage]]'''
'''  [[Acebutolol indications and usage|Indications and Usage]]'''

Revision as of 03:45, 10 February 2014

Acebutolol
SECTRAL® FDA Package Insert
Indications and Usage
Dosage and Administration
Dosage Forms and Strengths
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
How Supplied/Storage and Handling
Patient Counseling Information
Labels and Packages
Clinical Trials
ClinicalTrials.gov

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sheng Shi, M.D. [2]

For patient information about Acebutolol, click here.

Synonyms / Brand Names: SECTRAL®

Overview

Sectral (acebutolol HCl) is a selective, hydrophilic beta-adrenoreceptor blocking agent with mild intrinsic sympathomimetic activity for use in treating patients with hypertension and ventricular arrhythmias

Category

Beta blockers

FDA Package Insert

SECTRAL (acebutolol hydrochloride) capsule

Indications and Usage | Dosage and Administration | Dosage Forms and Strengths | Contraindications | Warnings and Precautions | Adverse Reactions | Drug Interactions | Use in Specific Populations | Overdosage | Description | Clinical Pharmacology | Nonclinical Toxicology | How Supplied/Storage and Handling | Patient Counseling Information | Labels and Packages

Mechanism of Action

The mechanism of action has not been definitively established. Possible factors that may be involved include: (1) decreased heart rate, (2) decreased myocardial contractility, (3) diminution of tonic sympathetic outflow to the periphery from cerebral vasomotor centers, (4) suppression of renin activity and (5) vasodilation and decreased peripheral vascular resistance.

References